Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1982 Oct;35(10):1118–1121. doi: 10.1136/jcp.35.10.1118

Antinuclear antibody-negative systemic lupus erythematosus-how common?

K C McHardy, C H Horne, J Rennie
PMCID: PMC497894  PMID: 6982285

Abstract

A review of five years' DNA-binding antibody results in a routine service laboratory revealed 38 patients who had high DNA-binding capacity (DNA-bc) but no antinuclear antibodies (ANA). On retrospective case note analysis, 22 patients (58%) were thought to have systemic lupus erythematosus (SLE), although only six (16%) fulfilled the preliminary classification criteria of the American Rheumatism Association (ARA). Our findings indicate that ANA-negative SLE is commoner than generally realised and lead us to recommended the measurement of DNA-bc in every case where clinically appropriate.

Full text

PDF
1121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BECK J. S. Variations in the morphological patterns of "autoimmune" nuclear fluorescence. Lancet. 1961 Jun 3;1(7188):1203–1205. doi: 10.1016/s0140-6736(61)91944-4. [DOI] [PubMed] [Google Scholar]
  2. Bartholomew B. A. Antinuclear antibody tests as a clinically selected screening procedure. Am J Clin Pathol. 1974 Apr;61(4):495–499. doi: 10.1093/ajcp/61.4.495. [DOI] [PubMed] [Google Scholar]
  3. Bennett R., Hughes G. R., Bywaters E. G., Holt P. J. Neuropsychiatric problems in systemic lupus erythematosus. Br Med J. 1972 Nov 11;4(5836):342–345. doi: 10.1136/bmj.4.5836.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bohan A. Seronegative systemic lupus erythematosus. J Rheumatol. 1979 Sep-Oct;6(5):534–540. [PubMed] [Google Scholar]
  5. Canoso J. J., Cohen A. S. A review of the use, evaluations, and criticisms of the preliminary criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1979 Aug;22(8):917–921. doi: 10.1002/art.1780220817. [DOI] [PubMed] [Google Scholar]
  6. DUBOIS E. L., TUFFANELLI D. L. CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES. JAMA. 1964 Oct 12;190:104–111. doi: 10.1001/jama.1964.03070150014003. [DOI] [PubMed] [Google Scholar]
  7. Davis P., Atkins B., Josse R. G., Hughes G. R. Criteria for classification of S.L.E. Br Med J. 1973 Jul 14;3(5871):88–89. doi: 10.1136/bmj.3.5871.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. El-Ghobarey A. E., Sloane D. J., Whaley K. The clinical significance of the antinuclear antibody test as a screening procedure for DNA antibodies in SLE. Scott Med J. 1980 Oct;25(4):293–298. doi: 10.1177/003693308002500409. [DOI] [PubMed] [Google Scholar]
  9. Estes D., Christian C. L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971 Mar;50(2):85–95. doi: 10.1097/00005792-197103000-00001. [DOI] [PubMed] [Google Scholar]
  10. Fessel W. J. ANA-negative systemic lupus erythematosus. Am J Med. 1978 Jan;64(1):80–86. doi: 10.1016/0002-9343(78)90181-x. [DOI] [PubMed] [Google Scholar]
  11. Fessel W. J. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med. 1974 Dec;134(6):1027–1035. [PubMed] [Google Scholar]
  12. Gibson T., Myers A. R. Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis. 1975 Oct;35(5):398–406. doi: 10.1136/ard.35.5.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gladman D. D., Chalmers A., Urowitz M. B. Systemic lupus erythematosus with negative LE cells and antinuclear factor. J Rheumatol. 1978 Summer;5(2):142–147. [PubMed] [Google Scholar]
  14. HARVEY A. M., SHULMAN L. E., TUMULTY P. A., CONLEY C. L., SCHOENRICH E. H. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954 Dec;33(4):291–437. [PubMed] [Google Scholar]
  15. Holian J., Griffiths I. D., Glass D. N., Maini R. N., Scott J. T. Human anti-DNA antibody: reference standards for diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 1975 Oct;34(5):438–443. doi: 10.1136/ard.34.5.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hughes G. R., Cohen S. A., Christian C. L. Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis. 1971 May;30(3):259–264. doi: 10.1136/ard.30.3.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jain S., Markham R., Thomas H. C., Sherlock S. Double-stranded DNA-binding capacity of serum in acute and chronic liver disease. Clin Exp Immunol. 1976 Oct;26(1):35–41. [PMC free article] [PubMed] [Google Scholar]
  18. Johnson R. T., Richardson E. P. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968 Jul;47(4):337–369. doi: 10.1097/00005792-196807000-00002. [DOI] [PubMed] [Google Scholar]
  19. Lee P., Urowitz M. B., Bookman A. A., Koehler B. E., Smythe H. A., Gordon D. A., Ogryzlo M. A. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med. 1977 Jan;46(181):1–32. [PubMed] [Google Scholar]
  20. Maddison P. J., Provost T. T., Reichlin M. Serological findings in patients with "ANA-negative" systemic lupus erythematosus. Medicine (Baltimore) 1981 Mar;60(2):87–94. doi: 10.1097/00005792-198103000-00002. [DOI] [PubMed] [Google Scholar]
  21. POLLAK V. E., PIRANI C. L., SCHWARTZ F. D. THE NATURAL HISTORY OF THE RENAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. J Lab Clin Med. 1964 Apr;63:537–550. [PubMed] [Google Scholar]
  22. Pincus T., Schur P. H., Rose J. A., Decker J. L., Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969 Sep 25;281(13):701–705. doi: 10.1056/NEJM196909252811304. [DOI] [PubMed] [Google Scholar]
  23. Provost T. T., Reichlin M. Antinuclear antibody-negative systemic lupus erythematosus. I. Anti-Ro(SSA) and anti-La(SSB) antibodies. J Am Acad Dermatol. 1981 Jan;4(1):84–89. doi: 10.1016/s0190-9622(81)70013-6. [DOI] [PubMed] [Google Scholar]
  24. SHEARN M. A., PIROFSKY B. Disseminated lupus erythematosus; analysis of thirty-four cases. AMA Arch Intern Med. 1952 Dec;90(6):790–807. doi: 10.1001/archinte.1952.00240120065007. [DOI] [PubMed] [Google Scholar]
  25. WINKELMANN R. K. Diagnosis and treatment of lupus erythematosus, dermatomyositis, and scleroderma, with emphasis on cutaneous findings. J Chronic Dis. 1961 May;13:401–410. doi: 10.1016/0021-9681(61)90026-1. [DOI] [PubMed] [Google Scholar]
  26. Wold R. T., Young F. E., Tan E. M., Farr R. S. Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid. Science. 1968 Aug 23;161(3843):806–807. doi: 10.1126/science.161.3843.806. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES